Live Breaking News & Updates on Abt Bio Pharma Solutions
Stay updated with breaking news from Abt bio pharma solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Axxcess Wealth Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 107,473 shares of the healthcare product maker’s stock after buying an additional 9,763 shares during […] ....
ARS Wealth Advisors Group LLC grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,002 shares of the healthcare product maker’s stock after purchasing an additional 876 shares during […] ....
Arcblock (ABT) traded 15.2% higher against the dollar during the one day period ending at 22:00 PM Eastern on May 3rd. One Arcblock token can now be bought for about $3.40 or 0.00005399 BTC on popular cryptocurrency exchanges. Arcblock has a market capitalization of $335.06 million and $27.95 million worth of Arcblock was traded on […] ....
Victory Capital Management Inc. lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 665,391 shares of the healthcare product maker’s stock after acquiring an additional 40,702 shares during the […] ....
U.S. Capital Wealth Advisors LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 69.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 32,729 shares of the healthcare product maker’s stock after acquiring an additional 13,461 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Abbott Laboratories were worth […] ....